Showing results (811-820 of 830) with videos related to
Sort By:
Pageof 83
The Lancet. Diabetes & Endocrinology|April 16, 2014
The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and managementRobert A Hegele, Henry N Ginsberg, M John Chapman, et al.European Heart Journal|April 27, 2017
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus PanelBrian A Ference, Henry N Ginsberg, Ian Graham, et al.Clinical Chemistry and Laboratory Medicine|December 20, 2019
Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLMMichel R Langlois, Børge G Nordestgaard, Anne Langsted, et al.Atherosclerosis|January 14, 2020
Quantifying atherogenic lipoproteins for lipid-lowering strategies: Consensus-based recommendations from EAS and EFLMBørge G Nordestgaard, Michel R Langlois, Anne Langsted, et al.The Lancet. Diabetes & Endocrinology|June 2, 2016
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia PanelRaul D Santos, Samuel S Gidding, Robert A Hegele, et al.European Heart Journal|August 20, 2013
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis SocietyBørge G Nordestgaard, M John Chapman, Steve E Humphries, et al.Atherosclerosis. Supplements|September 16, 2011
Familial hypercholesterolaemia: a model of care for AustralasiaGerald F Watts, David R Sullivan, Nicola Poplawski, et al.The Lancet. Diabetes & Endocrinology|August 4, 2024
Long-term sex differences in atherosclerotic cardiovascular disease in individuals with heterozygous familial hypercholesterolaemia in Spain: a study using data from SAFEHEART, a nationwide, multicentre, prospective cohort studyLeopoldo Pérez de Isla, Antonio J Vallejo-Vaz, Gerald F Watts, et al.Journal of the American College of Cardiology|July 24, 2024
Lipidomic Risk Score to Enhance Cardiovascular Risk Stratification for Primary PreventionJingqin Wu, Corey Giles, Aleksandar Dakic, et al.European Heart Journal|July 24, 2014
Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis SocietyMarina Cuchel, Eric Bruckert, Henry N Ginsberg, et al.Pageof 83